Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Nutr Metab Cardiovasc Dis ; 18(7): 483-91, 2008 Sep.
Article in English | MEDLINE | ID: mdl-17964767

ABSTRACT

BACKGROUND AND AIMS: Dietary therapy using phytosterols can reinforce statin treatment; however the value of a low-dose combination of those agents remains to be investigated. Plant sterols (PS), dissolved in diacylglycerol (DAG) oil, (PS/DAG) can be effective at a relatively low dose. The objective of the present study was to examine the effect of PS/DAG oil on blood cholesterol concentrations in hypercholesterolemic outpatients on low-dose pravastatin (10 mg/day). METHODS AND RESULTS: The patients (n=61) were randomly assigned to one of three groups, who consumed TAG (control), DAG or PS/DAG oil. The average intake of PS from the PS/DAG oil during the test period was significantly higher than that for TAG and DAG oils (502 vs. 49 and 38 mg/day, P<0.05). Significant cholesterol-lowering effects from the baseline were observed in the case of the PS/DAG oil treatment alone. Changes in low-density lipoprotein (LDL) cholesterol were inversely correlated with baseline serum campesterol concentrations (r=-0.560, P<0.05), but not baseline LDL cholesterol concentrations. In addition, serum apolipoprotein B concentrations were reduced to a greater extent in subjects with high versus low levels of baseline campesterol (-13.2 mg/dL vs. -3.1 mg/dL, P<0.05). Furthermore, there was a mild, but significant reduction in serum lipoprotein (a) concentration from the baseline (-5.9 mg/dL), which was correlated with the reduction in serum apolipoprotein B concentration (r=0.596, P<0.05). CONCLUSION: A low-dose combination of PS/DAG oil and pravastatin may be a useful strategy for further ameliorating blood cholesterol and lipoprotein (a) concentrations for hypercholesterolemic patients with a low response to pravastatin.


Subject(s)
Anticholesteremic Agents/therapeutic use , Cholesterol/blood , Hypercholesterolemia/drug therapy , Phytosterols/therapeutic use , Pravastatin/therapeutic use , Adult , Aged , Diglycerides/administration & dosage , Dose-Response Relationship, Drug , Double-Blind Method , Drug Synergism , Female , Humans , Hypercholesterolemia/blood , Lipoprotein(a)/blood , Male , Middle Aged , Phytosterols/administration & dosage , Solubility , Treatment Outcome , Triglycerides/administration & dosage , Triglycerides/chemistry
2.
J Atheroscler Thromb ; 10(1): 57-62, 2003.
Article in English | MEDLINE | ID: mdl-12621166

ABSTRACT

Paraoxonase (PON), an HDL- associated enzyme, may protect against the development of atherosclerosis. Single nucleotide polymorphisms of PON have been reported to be associated with an incidence of coronary heart diseases. We investigated the effect of PON R192Q variants on serum lipid profile after caloric restriction in nondiabetic healthy males. After caloric restriction for 12 weeks, the levels of high-density lipoprotein cholesterol (HDL-C) increased in the subjects carrying RR genotype, but not in the QR and QQ genotypes. The changes in HDL-C from the baseline values in the RR genotype were significantly different from those in the QR and QQ genotypes. Although the changes in lipoprotein lipase activity were not different among three genotypes, we observed a significant difference in the changes in hepatic lipase (HL) activity after caloric restriction, namely, a decrease in the RR genotype and an increase in the subjects carrying the Q allele. In addition, the changes in fasting insulin levels significantly correlated with those in HDL-C levels in the RR genotype, not in the QR and QQ genotypes. PON R192Q polymorphism could affect HDL-C levels after caloric restriction presumably due to decreased HL activity and altered insulin resistance.


Subject(s)
Caloric Restriction , Cholesterol, HDL/blood , Esterases/genetics , Genetic Variation , Genotype , Adult , Aryldialkylphosphatase , Blood Chemical Analysis , DNA/analysis , Humans , Insulin/blood , Insulin/metabolism , Lipids/blood , Male , Middle Aged , Polymerase Chain Reaction , Polymorphism, Genetic
3.
AJNR Am J Neuroradiol ; 23(2): 221-4, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11847045

ABSTRACT

We describe the case of a 54-year-old woman with a clinical diagnosis of Churg-Strauss syndrome (CSS). The patient had a fever of unknown origin, severe headache, progressing left ophthalmoplegia, and visual acuity disturbance. MR imaging revealed diffuse and thick hypointense lesions on T2-weighted images in the frontal meninges and anterior falx cerebri with diffuse enhancement. Similar lesions were also detected in the left superior ophthalmic fissure to the cavernous sinus. Nodular lesions in the fourth ventricle, which might have been the cause of hydrocephalus, were hypointense on T2-weighted images. These MR imaging findings suggested remote granulomatous involvement in the meninges and choroid plexus associated with CSS. To our knowledge, remote meningeal involvement in association with CSS has not been previously reported.


Subject(s)
Brain/pathology , Churg-Strauss Syndrome/diagnosis , Magnetic Resonance Imaging , Meninges/pathology , Cavernous Sinus/pathology , Central Nervous System Diseases/complications , Central Nervous System Diseases/diagnosis , Choroid Plexus/pathology , Churg-Strauss Syndrome/complications , Female , Fourth Ventricle/pathology , Granuloma/diagnosis , Humans , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL